The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn:
“Are you a physician attending ESMO GI 24?
Join us in Munich from June 26-29 to discuss the future of immuno-oncology with our Medical Affairs team.
To Schedule a meeting, click here.”
Source: Agenus/LinkedIn
ESMO GI 2024 will take place in Munich, Germany, from 26 to 29 June 2024, as well as online, through a virtual platform.
Agenus (formerly Antigenics Inc.) is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology. The company is involved in developing checkpoint modulators (CPMs) and patient-specific anti-cancer vaccines. Agenus was founded in 1994 by Garo H. Armen and Pramod K. Srivastava. Agenus became a public company in February 2000 on the NASDAQ exchange.
Other posts from Agenus on OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023